CDK4/6 Inhibition Boosts PFS in Endometrial Cancer

(MedPage Today) -- Women with advanced, hormone receptor (HR)-positive cervical cancer lived more than twice as long without disease progression if they received the CDK inhibitor palbociclib in addition to hormonal therapy, a small randomized...